PECAM1 and neoplasm: Since angiogenesis is absolutely required to promote tumour growth, invasion andmetastasis31, in vivo evidence for anti-angiogeniceffects of DHS treatment was investigated by immunostaining of the tumoursections for two endothelial cell markers, such as PECAM-1, known as CD31, andendomucin (Fig. 4aC,D).